Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Ophthalmic Drug

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1178474

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1178474

Europe Pingueculum Drugs Market - Industry Trends and Forecast to 2029

PUBLISHED:
PAGES: 239 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Description

Table of Contents

List of Tables

The Europe pingueculum drugs market is projected to register a substantial CAGR of 5.9% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.

Market Segmentation:

Europe Pingueculum Drugs Market, By Treatment (Artificial Tears /Topical Lubricants, Steroid Eye Drops, Non-steroidal Anti Inflammatory Drops, and Others), Formulation Type (Eye Drops, Eye Ointments, and Others), Mode of Purchase (Prescription, Over the Counter), Drug Type (Branded, Generics), Population Type (Geriatric, Adults), End User (Hospitals, Speciality Clinics, Home Healthcare, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), Country (Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Luxembourg, and Rest of Europe) Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the Europe pingueculum drug market are:

Rise in the prevalence of pingueculum disease around the globe

Rise in the UV exposure to the individuals due to ozone defect casing pingueculum more frequent

Market Players:

Some of the major players operating in the Europe pingueculum drugs market are:

Akorn Operating Company LLC

Alcon Inc.

Amneal Pharmaceuticals LLC

Bausch & Lomb Incorporated

Bayer AG

Johnson & Johnson Consumer Inc.

Novartis AG

OASIS Medical, Inc.

SAGER PHARMA

Santen Pharmaceutical Co.

Johnson & Johnson Vision Care, Inc.

Similasan Corporation

Sylentis

Laboratoires Thea

Wellona Pharma

Zydus Group

Show more

TABLE OF CONTENTS

1 INTRODUCTION 43

  • 1.1 OBJECTIVES OF THE STUDY 43
  • 1.2 MARKET DEFINITION 43
  • 1.3 OVERVIEW OF THE EUROPE PINGUECULUM DRUGS MARKET 43
  • 1.4 CURRENCY AND PRICING 45
  • 1.5 LIMITATIONS 45
  • 1.6 MARKETS COVERED 46

2 EUROPE PINGUECULUM DRUGS MARKET: SEGMENTATION 48

  • 2.1 MARKETS COVERED 48
  • 2.2 GEOGRAPHICAL SCOPE 49
  • 2.3 YEARS CONSIDERED FOR THE STUDY 50
  • 2.4 CURRENCY AND PRICING 50
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 51
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
  • 2.7 MULTIVARIATE MODELLING 55
  • 2.8 TREATMENT LIFELINE CURVE 55
  • 2.9 DBMR MARKET POSITION GRID 56
  • 2.10 VENDOR SHARE ANALYSIS 58
  • 2.11 MARKET END-USER COVERAGE GRID 59
  • 2.12 SECONDARY SOURCES 60
  • 2.13 ASSUMPTIONS 60

3 EXECUTIVE SUMMARY 61

4 PREMIUM INSIGHTS 64

  • 4.1 EPIDERMIOLOGY 65
  • 4.2 PESTEL ANALYSIS 66
  • 4.3 PORTER'S FIVE FORCES 67
  • 4.4 PIPELINE ANALYSIS FOR THE EUROPE PINGUECULUM DRUGS MARKET 68
  • 4.5 INDUSTRIAL INSIGHTS: 69
  • 4.6 CONCLUSION: 69

5 EUROPE PINGUECULUM DRUGS MARKET: REGULATIONS 70

6 MARKET OVERVIEW 73

  • 6.1 DRIVERS 75
    • 6.1.1 RISING PREVALENCE OF PINGUECELA DISORDERS AND OCULAR PAINS 75
    • 6.1.2 RISE IN THE CHRONIC UV RADIATION EXPOSURE DUE TO OZONE DEFECT 75
    • 6.1.3 INCREASING AWARENESS AMONG PEOPLE FOR EYE-RELATED DISEASES 76
    • 6.1.4 RISING OPHTHALMIC EMERGENCIES IN THE GERIATRIC PATIENT 77
  • 6.2 RESTRAINTS 77
    • 6.2.1 STRINGENT RULES & REGULATIONS 77
    • 6.2.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT 78
  • 6.3 OPPORTUNITIES 79
    • 6.3.1 INITIATIVES AND PLANS TO LESSEN THE PREVALENCE OF EYE ILLNESSES 79
    • 6.3.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES 79
    • 6.3.3 INCREASE IN HEALTHCARE SPENDING AND ACCESSIBLE INCOME 80
  • 6.4 CHALLENGES 81
    • 6.4.1 ADVERSE EFFECTS OF STEROID EYE DROPS 81
    • 6.4.2 LACK OF SKILLED OPHTHALMOLOGISTS 82

7 EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT 83

  • 7.1 OVERVIEW 84
  • 7.2 ARTIFICIAL TEARS/TOPICAL LUBRICANTS 87
    • 7.2.1 DEMULCENT 87
    • 7.2.2 EMOLLIENTS 87
  • 7.3 STEROID EYE DROPS 88
    • 7.3.1 KETONE STEROIDS 89
      • 7.3.1.1 PREDNISOLONE 89
      • 7.3.1.2 DEXAMETHASONE 89
      • 7.3.1.3 FLUROMETHOLONE 89
      • 7.3.1.4 MEDRYSONE 89
      • 7.3.1.5 RIMEXOLONE 89
      • 7.3.1.6 OTHERS 89
    • 7.3.2 ESTER STEROID (LOTERPREDNOL) 90
  • 7.4 NON-STEROIDAL ANTI-INFLAMMATORY DROPS 90
  • 7.5 OTHERS 90

8 EUROPE PINGUECULUM DRUGS MARKET, BY FORMULATION 91

  • 8.1 OVERVIEW 92
  • 8.2 EYE DROPS 95
    • 8.2.1 EYE DROPS WITH PRESERVATIVES 95
    • 8.2.2 PRESERVATIVE-FREE EYE DROPS 95
  • 8.3 EYE OINTMENTS 96
    • 8.3.1 WITH PRESERVATIVES 96
    • 8.3.2 PRESERVATIVE-FREE 96
    • 8.3.3 OTHERS 96
  • 8.4 OTHERS 97

9 EUROPE PINGUECULUM DRUGS MARKET, MODE OF PURCHASE 98

  • 9.1 OVERVIEW 99
  • 9.2 PRESCRIPTION 102
  • 9.3 OVER THE COUNTER (OTC) 102

10 EUROPE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE 103

  • 10.1 OVERVIEW 104
  • 10.2 BRANDED 107
  • 10.3 GENERICS 107

11 EUROPE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE 108

  • 11.1 OVERVIEW 109
  • 11.2 GERIATRIC 112
    • 11.2.1 MALE 112
    • 11.2.2 FEMALE 112
  • 11.3 ADULTS 113
    • 11.3.1 MALE 113
    • 11.3.2 FEMALE 113

12 EUROPE PINGUECULUM DRUGS MARKET, BY END USER 114

  • 12.1 OVERVIEW 115
  • 12.2 HOSPITALS 118
  • 12.3 SPECIALTY CLINICS 118
  • 12.4 HOME HEALTHCARE 119
  • 12.5 OTHERS 119

13 EUROPE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL 120

  • 13.1 OVERVIEW 121
  • 13.2 RETAIL PHARMACIES 124
  • 13.3 HOSPITAL PHARMACIES 124
  • 13.4 ONLINE PHARMACIES 125
  • 13.5 OTHERS 125

14 EUROPE PINGUECULUM DRUGS MARKET, BY REGION 126

  • 14.1 EUROPE 127
    • 14.1.1 SPAIN 136
    • 14.1.2 RUSSIA 140
    • 14.1.3 TURKEY 144
    • 14.1.4 GERMANY 148
    • 14.1.5 ITALY 152
    • 14.1.6 U.K. 156
    • 14.1.7 FRANCE 160
    • 14.1.8 HUNGARY 164
    • 14.1.9 AUSTRIA 168
    • 14.1.10 SWITZERLAND 172
    • 14.1.11 NETHERLANDS 176
    • 14.1.12 POLAND 180
    • 14.1.13 IRELAND 184
    • 14.1.14 NORWAY 188
    • 14.1.15 LITHUANIA 192
    • 14.1.16 REST OF EUROPE 196

15 EUROPE PINGUECULUM DRUGS MARKET: COMPANY LANDSCAPE 197

  • 15.1 COMPANY SHARE ANALYSIS: EUROPE 197

16 SWOT ANALYSIS 198

17 COMPANY PROFILE 199

  • 17.1 ALCON INC. 199
    • 17.1.1 COMPANY SNAPSHOT 199
    • 17.1.2 REVENUE ANALYSIS 199
    • 17.1.3 COMPANY SHARE ANALYSIS 200
    • 17.1.4 PRODUCT PORTFOLIO 200
    • 17.1.5 RECENT DEVELOPMENT 200
  • 17.2 ABBVIE INC. 201
    • 17.2.1 COMPANY SNAPSHOT 201
    • 17.2.2 REVENUE ANALYSIS 201
    • 17.2.3 COMPANY SHARE ANALYSIS 202
    • 17.2.4 PRODUCT PORTFOLIO 202
    • 17.2.5 RECENT DEVELOPMENT 203
  • 17.3 BAUSCH & LOMB INCORPORATED 204
    • 17.3.1 COMPANY SNAPSHOT 204
    • 17.3.2 REVENUE ANALYSIS 204
    • 17.3.3 COMPANY SHARE ANALYSIS 205
    • 17.3.4 PRODUCT PORTFOLIO 205
    • 17.3.5 RECENT DEVELOPMENT 206
  • 17.4 BAYER AG 207
    • 17.4.1 COMPANY SNAPSHOT 207
    • 17.4.2 REVENUE ANALYSIS 207
    • 17.4.3 COMPANY SHARE ANALYSIS 208
    • 17.4.4 PRODUCT PORTFOLIO 208
    • 17.4.5 RECENT DEVELOPMENTS 208
  • 17.5 JOHNSON & JOHNSON VISION CARE, INC. 209
    • 17.5.1 COMPANY SNAPSHOT 209
    • 17.5.2 REVENUE ANALYSIS 209
    • 17.5.3 COMPANY SHARE ANALYSIS 210
    • 17.5.4 PRODUCT PORTFOLIO 210
    • 17.5.5 RECENT DEVELOPMENT 210
  • 17.6 AKORN OPERATING COMPANY LLC 211
    • 17.6.1 COMPANY SNAPSHOT 211
    • 17.6.2 . PRODUCT PORTFOLIO 211
    • 17.6.3 RECENT DEVELOPMENT 211
  • 17.7 AMNEAL PHARMACEUTICALS LLC. 212
    • 17.7.1 COMPANY SNAPSHOT 212
    • 17.7.2 REVENUE ANALYSIS 212
    • 17.7.3 PRODUCT PORTFOLIO 213
    • 17.7.4 RECENT DEVELOPMENTS 213
  • 17.8 EYERIS VISIONCARE PVT. LTD. 214
    • 17.8.1 COMPANY SNAPSHOT 214
    • 17.8.2 PRODUCT PORTFOLIO 214
    • 17.8.3 RECENT DEVELOPMENTS 215
  • 17.9 LABORATOIRES THEA 216
    • 17.9.1 COMPANY SNAPSHOT 216
    • 17.9.2 PRODUCT PORTFOLIO 216
    • 17.9.3 RECENT DEVELOPMENT 217
  • 17.10 MAYA BIOTECH PRIVATE LIMITED 218
    • 17.10.1 COMPANY SNAPSHOT 218
    • 17.10.2 PRODUCT PORTFOLIO 218
    • 17.10.3 RECENT DEVELOPMENTS 219
  • 17.11 NOVARTIS AG 220
    • 17.11.1 COMPANY SNAPSHOT 220
    • 17.11.2 REVENUE ANALYSIS 220
    • 17.11.3 PRODUCT PORTFOLIO 221
    • 17.11.4 RECENT DEVELOPMENT 221
  • 17.12 OASIS MEDICAL, INC. 222
    • 17.12.1 COMPANY SNAPSHOT 222
    • 17.12.2 PRODUCT PORTFOLIO 222
    • 17.12.3 RECENT DEVELOPMENT 222
  • 17.13 PRESTIGE CONSUMER HEALTHCARE, INC. 223
    • 17.13.1 COMPANY SNAPSHOT 223
    • 17.13.2 PRODUCT PORTFOLIO 224
    • 17.13.3 RECENT DEVELOPMENT 224
  • 17.14 SAGER PHARMA 225
    • 17.14.1 COMPANY SNAPSHOT 225
    • 17.14.2 PRODUCT PORTFOLIO 225
    • 17.14.3 RECENT DEVELOPMENTS 225
  • 17.15 SANTEN PHARMACEUTICAL CO., LTD. 226
    • 17.15.1 COMPANY SNAPSHOT 226
    • 17.15.2 REVENUE ANALYSIS 226
    • 17.15.3 PRODUCT PORTFOLIO 227
    • 17.15.4 RECENT DEVELOPMENTS 227
  • 17.16 SIMILASAN CORPORATION 228
    • 17.16.1 COMPANY SNAPSHOT 228
    • 17.16.2 PRODUCT PORTFOLIO 228
    • 17.16.3 RECENT DEVELOPMENTS 228
  • 17.17 SPECTRA VISION CARE 229
    • 17.17.1 COMPANY SNAPSHOT 229
    • 17.17.2 PRODUCT PORTFOLIO 229
    • 17.17.3 RECENT DEVELOPMENTS 230
  • 17.18 SYLENTIS 231
    • 17.18.1 COMPANY SNAPSHOT 231
    • 17.18.2 PRODUCT PORTFOLIO 231
    • 17.18.3 RECENT DEVELOPMENTS 231
  • 17.19 WELLONA PHARMA 232
    • 17.19.1 COMPANY SNAPSHOT 232
    • 17.19.2 PRODUCT PORTFOLIO 232
    • 17.19.3 RECENT DEVELOPMENTS 232
  • 17.20 ZYDUS GROUP 233
    • 17.20.1 COMPANY SNAPSHOT 233
    • 17.20.2 REVENUE ANALYSIS 233
    • 17.20.3 PRODUCT PORTFOLIO 234
    • 17.20.4 RECENT DEVELOPMENTS 234

18 QUESTIONNAIRE 235

19 RELATED REPORTS 239

Show more

LIST OF TABLES

  • TABLE 1 EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 68
  • TABLE 2 EUROPE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 69
  • TABLE 3 EUROPE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 69
  • TABLE 4 EUROPE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 70
  • TABLE 5 EUROPE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 70
  • TABLE 6 EUROPE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 71
  • TABLE 7 EUROPE NON-STEROIDAL ANTI-INFLAMMATORY DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 72
  • TABLE 8 EUROPE OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 72
  • TABLE 9 EUROPE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 76
  • TABLE 10 EUROPE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 77
  • TABLE 11 EUROPE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 77
  • TABLE 12 EUROPE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 78
  • TABLE 13 EUROPE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 78
  • TABLE 14 EUROPE OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 79
  • TABLE 15 EUROPE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 83
  • TABLE 16 EUROPE PRESCRIPTION IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 84
  • TABLE 17 EUROPE OVER THE COUNTER (OTC) IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 84
  • TABLE 18 EUROPE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 88
  • TABLE 19 EUROPE BRANDED IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 89
  • TABLE 20 EUROPE GENERICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 89
  • TABLE 21 EUROPE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 93
  • TABLE 22 EUROPE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 94
  • TABLE 23 EUROPE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 94
  • TABLE 24 EUROPE ADULTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 95
  • TABLE 25 EUROPE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 95
  • TABLE 26 EUROPE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 99
  • TABLE 27 EUROPE HOSPITALS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 100
  • TABLE 28 EUROPE SPECIALTY CLINICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 100
  • TABLE 29 EUROPE HOME HEALTHCARE IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 101
  • TABLE 30 EUROPE OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 101
  • TABLE 31 EUROPE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 105
  • TABLE 32 EUROPE RETAIL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 106
  • TABLE 33 EUROPE HOSPITAL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 106
  • TABLE 34 EUROPE ONLINE PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 107
  • TABLE 35 EUROPE OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION) 107
  • TABLE 36 EUROPE PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION) 114
  • TABLE 37 EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 114
  • TABLE 38 EUROPE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 114
  • TABLE 39 EUROPE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 115
  • TABLE 40 EUROPE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 115
  • TABLE 41 EUROPE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 115
  • TABLE 42 EUROPE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 115
  • TABLE 43 EUROPE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 116
  • TABLE 44 EUROPE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 116
  • TABLE 45 EUROPE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 116
  • TABLE 46 EUROPE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 116
  • TABLE 47 EUROPE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 116
  • TABLE 48 EUROPE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 117
  • TABLE 49 EUROPE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 117
  • TABLE 50 EUROPE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 117
  • TABLE 51 SPAIN PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 118
  • TABLE 52 SPAIN ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 118
  • TABLE 53 SPAIN STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 118
  • TABLE 54 SPAIN KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 119
  • TABLE 55 SPAIN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 119
  • TABLE 56 SPAIN EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 119
  • TABLE 57 SPAIN EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 119
  • TABLE 58 SPAIN PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 120
  • TABLE 59 SPAIN PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 120
  • TABLE 60 SPAIN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 120
  • TABLE 61 SPAIN GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 120
  • TABLE 62 SPAIN ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 120
  • TABLE 63 SPAIN PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 121
  • TABLE 64 SPAIN PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 121
  • TABLE 65 RUSSIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 122
  • TABLE 66 RUSSIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 122
  • TABLE 67 RUSSIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 122
  • TABLE 68 RUSSIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 123
  • TABLE 69 RUSSIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 123
  • TABLE 70 RUSSIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 123
  • TABLE 71 RUSSIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 123
  • TABLE 72 RUSSIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 124
  • TABLE 73 RUSSIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 124
  • TABLE 74 RUSSIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 124
  • TABLE 75 RUSSIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 124
  • TABLE 76 RUSSIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 124
  • TABLE 77 RUSSIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 125
  • TABLE 78 RUSSIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 125
  • TABLE 79 TURKEY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 126
  • TABLE 80 TURKEY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 126
  • TABLE 81 TURKEY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 126
  • TABLE 82 TURKEY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 127
  • TABLE 83 TURKEY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 127
  • TABLE 84 TURKEY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 127
  • TABLE 85 TURKEY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 127
  • TABLE 86 TURKEY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 128
  • TABLE 87 TURKEY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 128
  • TABLE 88 TURKEY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 128
  • TABLE 89 TURKEY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 128
  • TABLE 90 TURKEY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 128
  • TABLE 91 TURKEY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 129
  • TABLE 92 TURKEY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 129
  • TABLE 93 GERMANY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 130
  • TABLE 94 GERMANY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 130
  • TABLE 95 GERMANY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 130
  • TABLE 96 GERMANY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 131
  • TABLE 97 GERMANY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 131
  • TABLE 98 GERMANY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 131
  • TABLE 99 GERMANY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 131
  • TABLE 100 GERMANY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 132
  • TABLE 101 GERMANY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 132
  • TABLE 102 GERMANY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 132
  • TABLE 103 GERMANY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 132
  • TABLE 104 GERMANY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 132
  • TABLE 105 GERMANY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 133
  • TABLE 106 GERMANY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 133
  • TABLE 107 ITALY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 134
  • TABLE 108 ITALY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 134
  • TABLE 109 ITALY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 134
  • TABLE 110 ITALY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 135
  • TABLE 111 ITALY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 135
  • TABLE 112 ITALY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 135
  • TABLE 113 ITALY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 135
  • TABLE 114 ITALY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 136
  • TABLE 115 ITALY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 136
  • TABLE 116 ITALY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 136
  • TABLE 117 ITALY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 136
  • TABLE 118 ITALY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 136
  • TABLE 119 ITALY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 137
  • TABLE 120 ITALY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 137
  • TABLE 121 U.K. PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 138
  • TABLE 122 U.K. ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 138
  • TABLE 123 U.K. STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 138
  • TABLE 124 U.K. KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 139
  • TABLE 125 U.K. PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 139
  • TABLE 126 U.K. EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 139
  • TABLE 127 U.K. EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 139
  • TABLE 128 U.K. PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 140
  • TABLE 129 U.K. PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 140
  • TABLE 130 U.K. PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 140
  • TABLE 131 U.K. GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 140
  • TABLE 132 U.K. ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 140
  • TABLE 133 U.K. PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 141
  • TABLE 134 U.K. PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 141
  • TABLE 135 FRANCE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 142
  • TABLE 136 FRANCE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 142
  • TABLE 137 FRANCE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 142
  • TABLE 138 FRANCE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 143
  • TABLE 139 FRANCE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 143
  • TABLE 140 FRANCE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 143
  • TABLE 141 FRANCE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 143
  • TABLE 142 FRANCE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 144
  • TABLE 143 FRANCE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 144
  • TABLE 144 FRANCE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 144
  • TABLE 145 FRANCE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 144
  • TABLE 146 FRANCE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 144
  • TABLE 147 FRANCE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 145
  • TABLE 148 FRANCE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 145
  • TABLE 149 HUNGARY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 14
  • TABLE 150 HUNGARY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 146
  • TABLE 151 HUNGARY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 146
  • TABLE 152 HUNGARY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 147
  • TABLE 153 HUNGARY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 147
  • TABLE 154 HUNGARY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 147
  • TABLE 155 HUNGARY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 147
  • TABLE 156 HUNGARY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 148
  • TABLE 157 HUNGARY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 148
  • TABLE 158 HUNGARY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 148
  • TABLE 159 HUNGARY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 148
  • TABLE 160 HUNGARY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 148
  • TABLE 161 HUNGARY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 149
  • TABLE 162 HUNGARY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 149
  • TABLE 163 AUSTRIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 150
  • TABLE 164 AUSTRIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 150
  • TABLE 165 AUSTRIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 150
  • TABLE 166 AUSTRIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 151
  • TABLE 167 AUSTRIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 151
  • TABLE 168 AUSTRIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 151
  • TABLE 169 AUSTRIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 151
  • TABLE 170 AUSTRIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 152
  • TABLE 171 AUSTRIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 152
  • TABLE 172 AUSTRIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 152
  • TABLE 173 AUSTRIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 152
  • TABLE 174 AUSTRIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 152
  • TABLE 175 AUSTRIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 153
  • TABLE 176 AUSTRIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 153
  • TABLE 177 SWITZERLAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 154
  • TABLE 178 SWITZERLAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 154
  • TABLE 179 SWITZERLAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 154
  • TABLE 180 SWITZERLAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 155
  • TABLE 181 SWITZERLAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 155
  • TABLE 182 SWITZERLAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 155
  • TABLE 183 SWITZERLAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 155
  • TABLE 184 SWITZERLAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 156
  • TABLE 185 SWITZERLAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 156
  • TABLE 186 SWITZERLAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 156
  • TABLE 187 SWITZERLAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 156
  • TABLE 188 SWITZERLAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 156
  • TABLE 189 SWITZERLAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 157
  • TABLE 190 SWITZERLAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 157
  • TABLE 191 NETHERLANDS PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 158
  • TABLE 192 NETHERLANDS ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 158
  • TABLE 193 NETHERLANDS STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 158
  • TABLE 194 NETHERLANDS KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 158
  • TABLE 195 NETHERLANDS PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 159
  • TABLE 196 NETHERLANDS EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 159
  • TABLE 197 NETHERLANDS EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 159
  • TABLE 198 NETHERLANDS PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 159
  • TABLE 199 NETHERLANDS PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 160
  • TABLE 200 NETHERLANDS PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 160
  • TABLE 201 NETHERLANDS GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 160
  • TABLE 202 NETHERLANDS ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 160
  • TABLE 203 NETHERLANDS PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 161
  • TABLE 204 NETHERLANDS PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 161
  • TABLE 205 POLAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 162
  • TABLE 206 POLAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 162
  • TABLE 207 POLAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 162
  • TABLE 208 POLAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 163
  • TABLE 209 POLAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 163
  • TABLE 210 POLAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 163
  • TABLE 211 POLAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 163
  • TABLE 212 POLAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 164
  • TABLE 213 POLAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 164
  • TABLE 214 POLAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 164
  • TABLE 215 POLAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 164
  • TABLE 216 POLAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 164
  • TABLE 217 POLAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 165
  • TABLE 218 POLAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 165
  • TABLE 219 IRELAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 166
  • TABLE 220 IRELAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 166
  • TABLE 221 IRELAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 166
  • TABLE 222 IRELAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 167
  • TABLE 223 IRELAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 167
  • TABLE 224 IRELAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 167
  • TABLE 225 IRELAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 167
  • TABLE 226 IRELAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 168
  • TABLE 227 IRELAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 168
  • TABLE 228 IRELAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 168
  • TABLE 229 IRELAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 168
  • TABLE 230 IRELAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 168
  • TABLE 231 IRELAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 169
  • TABLE 232 IRELAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 169
  • TABLE 233 NORWAY PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 170
  • TABLE 234 NORWAY ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 170
  • TABLE 235 NORWAY STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 170
  • TABLE 236 NORWAY KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 171
  • TABLE 237 NORWAY PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 171
  • TABLE 238 NORWAY EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 171
  • TABLE 239 NORWAY EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 171
  • TABLE 240 NORWAY PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 172
  • TABLE 241 NORWAY PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 172
  • TABLE 242 NORWAY PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 172
  • TABLE 243 NORWAY GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 172
  • TABLE 244 NORWAY ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 172
  • TABLE 245 NORWAY PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 173
  • TABLE 246 NORWAY PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 173
  • TABLE 247 LITHUANIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 174
  • TABLE 248 LITHUANIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 174
  • TABLE 249 LITHUANIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 174
  • TABLE 250 LITHUANIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION) 175
  • TABLE 251 LITHUANIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 175
  • TABLE 252 LITHUANIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 175
  • TABLE 253 LITHUANIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION) 175
  • TABLE 254 LITHUANIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION) 176
  • TABLE 255 LITHUANIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION) 176
  • TABLE 256 LITHUANIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 176
  • TABLE 257 LITHUANIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 176
  • TABLE 258 LITHUANIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION) 176
  • TABLE 259 LITHUANIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION) 177
  • TABLE 260 LITHUANIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION) 177
  • TABLE 261 REST OF EUROPE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION) 178

LIST OF FIGURES

  • FIGURE 1 EUROPE PINGUECULUM DRUGS MARKET: SEGMENTATION 29
  • FIGURE 2 EUROPE PINGUECULUM DRUGS MARKET: DATA TRIANGULATION 32
  • FIGURE 3 EUROPE PINGUECULUM DRUGS MARKET: DROC ANALYSIS 33
  • FIGURE 4 EUROPE PINGUECULUM DRUGS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 34
  • FIGURE 5 EUROPE PINGUECULUM DRUGS MARKET: COMPANY RESEARCH ANALYSIS 34
  • FIGURE 6 EUROPE PINGUECULUM DRUGS MARKET: INTERVIEW DEMOGRAPHICS 35
  • FIGURE 7 EUROPE PINGUECULUM DRUGS MARKET: DBMR POSITION GRID 37
  • FIGURE 8 EUROPE PINGUECULUM DRUGS MARKET: VENDOR SHARE ANALYSIS 39
  • FIGURE 9 EUROPE PINGUECULUM DRUGS MARKET: END USER COVERAGE GRID 40
  • FIGURE 10 EUROPE PINGUECULUM DRUGS MARKET: SEGMENTATION 44
  • FIGURE 11 INCREASING PREVALENCE OF OPHTHALMIC DISORDERS AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE EUROPE PINGUECULUM DRUGS MARKET GROWTH FROM 2022 TO 2029 45
  • FIGURE 12 ARTIFICIAL TEARS/TOPICAL LUBRICANTS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE EUROPE PINGUECULUM DRUGS MARKET FROM 2022 & 2029 45
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE PINGUECULUM DRUGS MARKET 55
  • FIGURE 14 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT, 2021 65
  • FIGURE 15 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT, 2022-2029 (USD MILLION) 66
  • FIGURE 16 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT, CAGR (2022-2029) 66
  • FIGURE 17 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT, LIFELINE CURVE 67
  • FIGURE 18 EUROPE PINGUECULUM DRUGS MARKET: BY FORMULATION, 2021 73
  • FIGURE 19 EUROPE PINGUECULUM DRUGS MARKET: BY FORMULATION, 2022-2029 (USD MILLION) 74
  • FIGURE 20 EUROPE PINGUECULUM DRUGS MARKET: BY FORMULATION, CAGR (2022-2029) 74
  • FIGURE 21 EUROPE PINGUECULUM DRUGS MARKET: BY FORMULATION, LIFELINE CURVE 75
  • FIGURE 22 EUROPE PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2021 80
  • FIGURE 23 EUROPE PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2022-2029 (USD MILLION) 81
  • FIGURE 24 EUROPE PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, CAGR (2022-2029) 81
  • FIGURE 25 EUROPE PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, LIFELINE CURVE 82
  • FIGURE 26 EUROPE PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2021 85
  • FIGURE 27 EUROPE PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2022-2029 (USD MILLION) 86
  • FIGURE 28 EUROPE PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, CAGR (2022-2029) 86
  • FIGURE 29 EUROPE PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, LIFELINE CURVE 87
  • FIGURE 30 EUROPE PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2021 90
  • FIGURE 31 EUROPE PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2022-2029 (USD MILLION) 91
  • FIGURE 32 EUROPE PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, CAGR (2022-2029) 91
  • FIGURE 33 EUROPE PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, LIFELINE CURVE 92
  • FIGURE 34 EUROPE PINGUECULUM DRUGS MARKET: BY END USER, 2021 96
  • FIGURE 35 EUROPE PINGUECULUM DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION) 97
  • FIGURE 36 EUROPE PINGUECULUM DRUGS MARKET: BY END USER, CAGR (2022-2029) 97
  • FIGURE 37 EUROPE PINGUECULUM DRUGS MARKET: BY END USER, LIFELINE CURVE 98
  • FIGURE 38 EUROPE PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021 102
  • FIGURE 39 EUROPE PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION) 103
  • FIGURE 40 EUROPE PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029) 103
  • FIGURE 41 EUROPE PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 104
  • FIGURE 42 EUROPE PINGUECULUM DRUGS MARKET: SNAPSHOT (2021) 109
  • FIGURE 43 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2021) 111
  • FIGURE 44 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029) 111
  • FIGURE 45 EUROPE PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029) 112
  • FIGURE 46 EUROPE PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029) 112
  • FIGURE 47 EUROPE PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%) 178
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!